Literature DB >> 3839661

Disseminated Curvularia infection.

S M de la Monte, G M Hutchins.   

Abstract

Curvularia is a saprophyte that rarely causes infection, and then usually occurs in immunocompromised patients. A 41-year-old man, previously in good health, developed pulmonary and cerebral infection with Curvularia lunata. With surgery and amphotericin B therapy, he recovered and was free of infection one year later.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3839661

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  6 in total

Review 1.  Curvularia geniculata fungal peritonitis: a case report with review of literature.

Authors:  T J Vachharajani; F Zaman; S Latif; R Penn; K D Abreo
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

2.  Fatal cerebral phaeohyphomycosis due to Curvularia lunata in an immunocompetent patient.

Authors:  Elliot Carter; Carole Boudreaux
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

3.  Optic atrophy due to Curvularia lunata mucocoele.

Authors:  Tai Smith; Tony Goldschlager; Nigel Mott; Tom Robertson; Scott Campbell
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

Review 4.  Hyalohyphomycosis and phaeohyphomycosis: two global disease entities of public health importance.

Authors:  L Ajello
Journal:  Eur J Epidemiol       Date:  1986-12       Impact factor: 8.082

5.  Curvularia lunata peritonitis complicating peritoneal dialysis.

Authors:  J O Lopes; S H Alves; J P Benevenga; F B Brauner; M S Castro; E Melchiors
Journal:  Mycopathologia       Date:  1994-08       Impact factor: 2.574

6.  Curvularia alcornii Aortic Pseudoaneurysm Following Aortic Valve Replacement: Case Report and Review of the Literature.

Authors:  Shanti Narayanasamy; Adam R Williams; Wiley A Schell; Rebekah W Moehring; Barbara D Alexander; Thuy Le; Ramesh A Bharadwaj; Michelle McGauvran; Jacob N Schroder; John R Perfect
Journal:  Open Forum Infect Dis       Date:  2021-11-03       Impact factor: 3.835

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.